Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Breast Cancer

  Free Subscription


Articles published in Clin Breast Cancer

Retrieve available abstracts of 220 articles:
HTML format



Single Articles


    October 2022
  1. LIU X, Tao L, Wang M, Li H, et al
    ABSDELL Model: Development and Internal Validation of a Risk Prediction Model of LVEF Decline in Breast Cancer Patients Treated With Trastuzumab.
    Clin Breast Cancer. 2022 Oct 23. pii: S1526-8209(22)00234.
    PubMed     Abstract available


  2. TORRES-BALANZA S, Fuentes-Aparicio L, Mena-Del Horno S, Martinez-Aspas A, et al
    Sexual Perception in Spanish Female Breast Cancer Survivors. Cross-Sectional Survey.
    Clin Breast Cancer. 2022 Oct 21. pii: S1526-8209(22)00233.
    PubMed     Abstract available


  3. LI ZH, Hong WJ, Guo XL, Li XR, et al
    Serratus Plane Block in Breast Cancer Surgery: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2022 Oct 19. pii: S1526-8209(22)00231.
    PubMed     Abstract available


  4. ZHENG H, Yang L, Hu J, Yang Y, et al
    Frequency and Influencing Factors of Shared Decision Making Among Breast Cancer Patients Receiving Surgery: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2022 Oct 18. pii: S1526-8209(22)00230.
    PubMed     Abstract available


  5. KIM YE, Cha JH, Kim HH, Shin HJ, et al
    The Accuracy of Mammography, Ultrasound, and Magnetic Resonance Imaging For the Measurement of Invasive Breast Cancer With Extensive Intraductal Components.
    Clin Breast Cancer. 2022 Oct 13. pii: S1526-8209(22)00227.
    PubMed     Abstract available


  6. ALDRICH J, Ekpo P, Rupji M, Switchenko JM, et al
    Racial Disparities in Clinical Outcomes on Investigator-Initiated Breast Cancer Clinical Trials at an Urban Medical Center.
    Clin Breast Cancer. 2022 Oct 13. pii: S1526-8209(22)00229.
    PubMed     Abstract available


  7. MARTIN S, Pflumio C, Trensz P, Schaff-Wendling F, et al
    Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kinase Inhibitor During Endocrine Treatment in Hormone-Sensitive Metastatic Breast Cancer Patients in the Context of the COVID-19 Outbreak.
    Clin Breast Cancer. 2022 Oct 13:S1526-8209(22)00228.
    PubMed     Abstract available


  8. PURSWANI JM, Nwankwo C, Adotama P, Gutierrez D, et al
    Radiation-induced skin changes after breast or chest wall irradiation in patients with breast cancer and skin of color: a systematic review.
    Clin Breast Cancer. 2022 Oct 8. pii: S1526-8209(22)00225.
    PubMed     Abstract available


  9. MEDIONI J, Scimeca D, Marquez YL, Leray E, et al
    Benefits of Homeopathic Complementary Treatment in Patients With Breast Cancer: A Retrospective Cohort Study Based on the French Nationwide Healthcare Database.
    Clin Breast Cancer. 2022 Oct 8. pii: S1526-8209(22)00224.
    PubMed     Abstract available


  10. ROY N, Villavisanis DF, Taub PJ
    Mitigating Financial Toxicity in Breast Cancer From Diagnosis to Treatment and Reconstruction.
    Clin Breast Cancer. 2022 Oct 4. pii: S1526-8209(22)00223.
    PubMed     Abstract available


  11. CARMON E, Alster T, Maly B, Kadouri L, et al
    Preoperative MRI for Evaluation of Extent of Disease in IDC Compared to ILC.
    Clin Breast Cancer. 2022;22:e745-e752.
    PubMed     Abstract available


  12. VIGGIANO T, Scott R, Sharpe R, Kasper C, et al
    Contrast Enhanced Mammography in Routine Clinical Practice: Frequency and Malignancy Rates of Enhancing Otherwise Occult Findings.
    Clin Breast Cancer. 2022;22:e736-e744.
    PubMed     Abstract available


  13. OSMAN MH, Rabie NA, Elmehrath AO, Bedair HM, et al
    Primary and Secondary Breast Sarcoma: Clinical and Pathological Characteristics, Prognostic Factors, and Nomograms for Predicting Survival.
    Clin Breast Cancer. 2022;22:e753-e763.
    PubMed     Abstract available


  14. GORDON PB
    Clinical Breast Examination is Important in Surveillance After Mastectomy.
    Clin Breast Cancer. 2022;22:e728.
    PubMed    


  15. FEI F, Siegal GP, Wei S
    Characterizing Clinicopathologic Features of Estrogen Receptor-Positive/Progesterone Receptor-Negative Breast Cancers.
    Clin Breast Cancer. 2022;22:e788-e797.
    PubMed     Abstract available


  16. CHEVLI N, Wang K, Haque W, Schwartz MR, et al
    Prognostic Impact of Radiation Therapy in Pure Mucinous Breast Carcinoma.
    Clin Breast Cancer. 2022;22:e807-e817.
    PubMed     Abstract available


  17. HENNESSY G, Boland MR, Bambrick M, Crone L, et al
    Value of Long-term Follow-up in Surgically Excised Lesions of Uncertain Malignant Potential in the Breast - Is 5 Years Necessary?
    Clin Breast Cancer. 2022;22:699-704.
    PubMed     Abstract available


  18. CORADINI D, Ambrogi F
    Differential Expression of the Genes Coding for Adipokines and Epithelial Cell Polarity Components in Women With Low and High Mammographic Density.
    Clin Breast Cancer. 2022;22:715-723.
    PubMed     Abstract available


  19. XU S, Luo W, Li M, Li Q, et al
    Circ_0001667 Promotes Adriamycin Resistance and Malignant Progression via Targeting the miR-193a-5p/Rap2A Molecular Axis in Breast Cancer.
    Clin Breast Cancer. 2022 Oct 1. pii: S1526-8209(22)00222.
    PubMed     Abstract available


    September 2022
  20. VAN HOUDT M, Han SN, Pauwels S, Billen J, et al
    Measurable Serum Estradiol and Estrone in Women 36-56 Years During Adjuvant Treatment With Aromatase Inhibitors for a Hormone Receptor-Positive Breast Cancer. Case Studies and Cross-sectional Study Using an Ultra-sensitive LC-MS/MS-Method.
    Clin Breast Cancer. 2022 Sep 28. pii: S1526-8209(22)00221.
    PubMed     Abstract available


  21. YADAV R, Kumar Y, Dahiya D, Bhatia A, et al
    Claudins: The Newly Emerging Targets in Breast Cancer.
    Clin Breast Cancer. 2022 Sep 9. pii: S1526-8209(22)00193.
    PubMed     Abstract available


  22. SINGH J, Sangwan N, Chauhan A, Avti PK, et al
    Integrative Expression, Survival Analysis and Cellular miR-2909 Molecular Interplay in MRN Complex Check Point Sensor Genes (MRN-CSG) Involved in Breast Cancer.
    Clin Breast Cancer. 2022 Sep 9. pii: S1526-8209(22)00192.
    PubMed     Abstract available


  23. ZHOU C, Xu L, Du Z, Lv Q, et al
    Geriatric Early-Stage Triple-Negative Breast Cancer Patients in Low-risk Population: Omitting Chemotherapy Based on Nomogram.
    Clin Breast Cancer. 2022 Sep 1. pii: S1526-8209(22)00190.
    PubMed     Abstract available


  24. HENDRIX N, Oestreicher N, Lalla D, Dolan CM, et al
    Residual Disease Burden After Neoadjuvant Therapy Among US Patients With High-Risk HER2-positive Early-Stage Breast Cancer: A Population Effectiveness Model.
    Clin Breast Cancer. 2022 Sep 1. pii: S1526-8209(22)00189.
    PubMed     Abstract available


    August 2022
  25. BARCO I, Garcia-Fdez A, Vallejo E, Tarroch X, et al
    Intraoperative Sentinel Node Fine-Needle Aspiration Biopsy as a Substitute for Whole Sentinel Node Excisional Biopsy in Breast Cancer Patients. Initial Report.
    Clin Breast Cancer. 2022 Aug 30. pii: S1526-8209(22)00185.
    PubMed     Abstract available


  26. WONG V, de Boer R, Baron-Hay S, Blum R, et al
    Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer.
    Clin Breast Cancer. 2022 Aug 30. pii: S1526-8209(22)00188.
    PubMed     Abstract available


  27. EDMONDS MC, Kim SJ, Wells M, Dahman B, et al
    A Mixed Method Approach to Examine Surveillance Mammography Experiences in Black and White Breast Cancer Survivors.
    Clin Breast Cancer. 2022 Aug 27. pii: S1526-8209(22)00186.
    PubMed     Abstract available


  28. NARUI K, Miura D, Hasegawa Y, Tachibana A, et al
    A Randomized Controlled Phase 2 Study of Neoadjuvant Eribulin Versus Paclitaxel in Women with Operable Breast Cancer: The JONIE-3 Study.
    Clin Breast Cancer. 2022 Aug 22. pii: S1526-8209(22)00184.
    PubMed     Abstract available


  29. BONADIO RC, Costa FA, Mendes SV, Araujo BJ, et al
    Disease Behavior and Treatment Response of Special Histological Types of Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2022 Aug 20. pii: S1526-8209(22)00182.
    PubMed     Abstract available


  30. DENG SX, Castelo M, Reel E, Naganathan G, et al
    High Risk Breast Cancer Screening is a Double Edged Sword: A Qualitative Study of Patient Perspectives on the Ontario High Risk Breast Cancer Screening Program.
    Clin Breast Cancer. 2022 Aug 19. pii: S1526-8209(22)00183.
    PubMed     Abstract available


  31. KOZAK MM, Karl J, von Eyben R, Guo F, et al
    Incidence of Brain Metastases in Women Treated With Neoadjuvant Chemotherapy for Breast Cancer: Implications for Screening.
    Clin Breast Cancer. 2022 Aug 11. pii: S1526-8209(22)00180.
    PubMed     Abstract available


  32. SHAH S, Shaing C, Khatib J, Lodrigues W, et al
    The Utility of Breast Cancer Index (BCI) Over Clinical Prognostic Tools for Predicting the Need for Extended Endocrine Therapy: A Safety Net Hospital Experience.
    Clin Breast Cancer. 2022 Aug 11. pii: S1526-8209(22)00179.
    PubMed     Abstract available


  33. TUGRAL A, Bakar Y, Akyol M
    The Characteristics of Pain Tolerance in Patients Who Underwent Unilateral Breast Cancer Surgery: The Effect of Handedness and Surgical Site to Assess the Potential Musculoskeletal Symptoms and Function.
    Clin Breast Cancer. 2022 Aug 6. pii: S1526-8209(22)00178.
    PubMed     Abstract available


  34. FERNANDEZ PEREZ I, Tunas LV, Corbacho DP, Benito CG, et al
    Utility of Genomic Platforms in Treatment Decisions in Axilla-Positive Breast Cancer.
    Clin Breast Cancer. 2022 Aug 5. pii: S1526-8209(22)00176.
    PubMed     Abstract available


  35. CHARATI FG, Shojaee L, Haghighat S, Esmaeili R, et al
    Motor Exercises Effect on Improving Shoulders Functioning, Functional Ability, Quality of Life, Depression and Anxiety For Women With Breast Cancer.
    Clin Breast Cancer. 2022 Aug 3. pii: S1526-8209(22)00171.
    PubMed     Abstract available


  36. YEP MANZANO IS, Agrawal A
    A Comparative Study of Drain in Oncoplastic Breast Conserving Surgery (Therapeutic Mammaplasty and Chest Wall Perforator Flap Partial Breast Reconstruction) vs. Mastectomy.
    Clin Breast Cancer. 2022;22:619-627.
    PubMed     Abstract available


  37. USLU H, Tosun M
    The benefit of superb microvascular imaging and shear wave elastography in differentiating metastatic axillary lymphadenopathy from lymphadenitis.
    Clin Breast Cancer. 2022;22:515-520.
    PubMed     Abstract available


  38. FREBAULT J, Bergom C, Cortina CS, Shukla ME, et al
    Treatment Patterns in Women Age 80 and Over With DCIS: A Report From the National Cancer Database.
    Clin Breast Cancer. 2022;22:547-552.
    PubMed     Abstract available


  39. SAYAN M, Kilic SS, Vergalasova I, Jan I, et al
    Risk Factors for the Development of Clinical and Subclinical Lymphedema Detected by Bioimpedance Spectroscopy.
    Clin Breast Cancer. 2022;22:553-559.
    PubMed     Abstract available


    July 2022
  40. WILLIAMS AD, Solis O, Sterbling HM, Murray A, et al
    Are We Overtreating Patients With T1a HER2+ Breast Cancer? An Analysis of the National Cancer Database.
    Clin Breast Cancer. 2022 Jul 29. pii: S1526-8209(22)00175.
    PubMed     Abstract available


  41. ALTUNDAG K
    Combination Treatment of Vinorelbine With Oral Cyclophosphamide or Capecitabine or Both Might Overcome Cross-resistance Against Eribulin in Advanced Breast Cancer.
    Clin Breast Cancer. 2022 Jul 25. pii: S1526-8209(22)00173.
    PubMed    


  42. TUNG I, Moldovan C, Wong V, De Boer R, et al
    Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study.
    Clin Breast Cancer. 2022 Jul 14. pii: S1526-8209(22)00155.
    PubMed     Abstract available


  43. MURCHISON S, Nichol A, Speers C, Gondara L, et al
    Locoregional Recurrence and Survival Outcomes in Breast Cancer Treated With Modern Neoadjuvant Chemotherapy: A Contemporary Population-based Analysis.
    Clin Breast Cancer. 2022 Jul 12. pii: S1526-8209(22)00145.
    PubMed     Abstract available


  44. SHARMA A, Searle K, Hasan S, Chan S, et al
    Exclusion of Patients With Brain Metastases in Published Phase III Clinical Trials for Advanced Breast Cancer.
    Clin Breast Cancer. 2022 Jul 11. pii: S1526-8209(22)00154.
    PubMed     Abstract available


  45. LAN B, Lv D, Sun X, Yang M, et al
    Genetic Variations in IFNGR1, BDNF and IL-10 May Predict the Susceptibility to Depression and Anxiety in Chinese Women With Breast Cancer.
    Clin Breast Cancer. 2022 Jul 9. pii: S1526-8209(22)00144.
    PubMed     Abstract available


  46. WANG J, Li Q, Luo Y, Han Y, et al
    Development and External Validation of a Clinical Nomogram for Individually Predicting Survival of Metaplastic Breast Cancer.
    Clin Breast Cancer. 2022 Jul 9. pii: S1526-8209(22)00142.
    PubMed     Abstract available


  47. VATHIOTIS IA, Trontzas I, Gavrielatou N, Gomatou G, et al
    Immune Checkpoint Blockade in Hormone Receptor-Positive Breast Cancer: Resistance Mechanisms and Future Perspectives.
    Clin Breast Cancer. 2022 Jul 7. pii: S1526-8209(22)00140.
    PubMed     Abstract available


  48. MORAES MO, Forte GC, Guimaraes ADSG, Grando MBFDP, et al
    Breast MRI: Simplifying Protocol and BI-RADS Categories.
    Clin Breast Cancer. 2022;22:e615-e622.
    PubMed     Abstract available


  49. DE VITA R, Villanucci A, Buccheri EM, Pozzi M, et al
    Extended Clinical Experience With Nipple-Sparing Mastectomy and Prepectoral Polyurethane Implant Positioning (BRAND4P method).
    Clin Breast Cancer. 2022;22:e623-e628.
    PubMed     Abstract available


  50. MICHA A, Parvaiz MA, O'Riordan L, MacNeill F, et al
    Isotope-Only Localization for Sentinel Lymph Node Biopsy - Medium-Term Oncological Outcomes.
    Clin Breast Cancer. 2022;22:e636-e640.
    PubMed     Abstract available


  51. XIE Y, Wang Q, Hu T, Chen R, et al
    Effect of a Novel Soaking Solution Used in Patients With Hand-Foot Syndrome as a Result of Capecitabine Treatment: A Randomized and Self-Controlled Trial.
    Clin Breast Cancer. 2022;22:e685-e690.
    PubMed     Abstract available


  52. OMISORE AD, Odedeyi AA, Famurewa OC, Olasehinde O, et al
    Practice, Perceptions, and Prospects of Mammography Screening in Nigeria: Insights From a National Survey of Female Health Workers.
    Clin Breast Cancer. 2022;22:462-472.
    PubMed     Abstract available


  53. TANVEER N, Dixit S, Jain P, Rani P, et al
    Static smartphone images supplemented by videoconferencing for breast telepathology.
    Clin Breast Cancer. 2022;22:455-461.
    PubMed     Abstract available


  54. MAYROVITZ HN, Weingrad DN
    Tissue Dielectric Constant Differentials between Malignant and Benign Breast Tumors.
    Clin Breast Cancer. 2022;22:473-477.
    PubMed     Abstract available


  55. AROLE V, Shafi S, Challa B, Parwani AV, et al
    Evaluating Mismatch Repair Status to Screen Clinical Advanced Breast Carcinomas for Immunotherapy: Experience From a Large Academic Institution.
    Clin Breast Cancer. 2022;22:e680-e684.
    PubMed     Abstract available


  56. KELLY BN, Webster AJ, Lamb L, Spivey T, et al
    Magnetic Seeds: An Alternative to Wire Localization for Nonpalpable Breast Lesions.
    Clin Breast Cancer. 2022;22:e700-e707.
    PubMed     Abstract available


    June 2022
  57. TUN SM, Alluri S, Rastegar V, Visintainer P, et al
    Mode of Detection of Second Events in Routine Surveillance of Early Stage Breast Cancer Patients.
    Clin Breast Cancer. 2022 Jun 29. pii: S1526-8209(22)00139.
    PubMed     Abstract available


  58. MENG X, Chang X, Wang X, Guo Y, et al
    Development and Validation a Survival Prediction Model and a Risk Stratification for Elderly Locally Advanced Breast Cancer.
    Clin Breast Cancer. 2022 Jun 26. pii: S1526-8209(22)00138.
    PubMed     Abstract available


  59. REDEMSKI T, Hamilton DG, Schuler S, Liang R, et al
    Rehabilitation for Women Undergoing Breast Cancer Surgery: A Systematic Review and Meta-Analysis of the Effectiveness of Early, Unrestricted Exercise Programs on Upper Limb Function.
    Clin Breast Cancer. 2022 Jun 24. pii: S1526-8209(22)00137.
    PubMed     Abstract available


  60. LIU H, Mei Y, Ma X, Zhang X, et al
    FRZB is Regulated by the Transcription Factor EGR1 and Inhibits the Growth and Invasion of Triple-Negative Breast Cancer Cells by Regulating the JAK/STAT3 Pathway.
    Clin Breast Cancer. 2022 Jun 2. pii: S1526-8209(22)00115.
    PubMed     Abstract available


  61. SHEIKH SE, Rathbone M, Chaudhary K, Joshi A, et al
    Rates and Outcomes of Breast Lesions of Uncertain Malignant Potential (B3) benchmarked against the National Breast Screening Pathology Audit; Improving Performance in a High Volume Screening Unit.
    Clin Breast Cancer. 2022;22:381-390.
    PubMed     Abstract available


  62. VRANIC S, Gatalica Z
    An Update on the Molecular and Clinical Characteristics of Apocrine Carcinoma of the Breast.
    Clin Breast Cancer. 2022;22:e576-e585.
    PubMed     Abstract available


  63. PETROLLA A, Hicks DG, Skinner KA, Wang X, et al
    Detailed Morphologic Evaluation of Breast Papillary Lesions on Core Biopsy Is Critical for Accurate Classification and Clinical Management: The Experience of an Academic Institute.
    Clin Breast Cancer. 2022;22:e552-e557.
    PubMed     Abstract available


  64. GU Y, Tian J, Ran H, Ren W, et al
    Can Ultrasound Elastography Help Better Manage Mammographic BI-RADS Category 4 Breast Lesions?
    Clin Breast Cancer. 2022;22:e407-e416.
    PubMed     Abstract available


    May 2022
  65. OKINES AFC, Irfan T, Mohammed K, Ring A, et al
    Vinorelbine After Prior Treatment With Eribulin for Advanced Breast Cancer: A Single-Centre Experience Suggesting Cross-Resistance.
    Clin Breast Cancer. 2022 May 27. pii: S1526-8209(22)00113.
    PubMed     Abstract available


  66. MICELI R, Cao C, Maolanon NN, Jacobs R, et al
    Plasma Profile of Immune Determinants Predicts Pathological Complete Response in Locally Advanced Breast Cancer Patients: A Pilot Study.
    Clin Breast Cancer. 2022 May 23. pii: S1526-8209(22)00112.
    PubMed     Abstract available


  67. HOUZARD S, Courtois E, Le Bihan Benjamin C, Erbault M, et al
    Monitoring Breast Cancer Care Quality at National and Local Level Using the French National Cancer Cohort.
    Clin Breast Cancer. 2022 May 21. pii: S1526-8209(22)00096.
    PubMed     Abstract available


  68. MALLA R, Puvalachetty K, Vempati RK, Marni R, et al
    Cancer Stem Cells and Circulatory Tumor Cells Promote Breast Cancer Metastasis.
    Clin Breast Cancer. 2022 May 19. pii: S1526-8209(22)00094.
    PubMed     Abstract available


  69. PATT D, Liu X, Li B, McRoy L, et al
    Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer: Flatiron Database Analysis.
    Clin Breast Cancer. 2022 May 5. pii: S1526-8209(22)00081.
    PubMed     Abstract available


  70. POTERALA JE, Havighurst T, Braun Wisinski K
    Characterization of Weakly Hormone Receptor (HR)-Positive, HER2-Negative Breast Cancer and Current Treatment Strategies.
    Clin Breast Cancer. 2022 May 5. pii: S1526-8209(22)00080.
    PubMed     Abstract available


    April 2022
  71. HEYLEN J, Punie K, Smeets A, Neven P, et al
    Elevated CA 15.3 in Newly Diagnosed Breast Cancer: A Retrospective Study.
    Clin Breast Cancer. 2022 Apr 30. pii: S1526-8209(22)00076.
    PubMed     Abstract available


  72. TONG QY, Liu R, Gao Y, Zhang K, et al
    Effect of Electroacupuncture Based on ERAS for Preoperative Anxiety in Breast Cancer Surgery: A Single-Center, Randomized, Controlled Trial.
    Clin Breast Cancer. 2022 Apr 30. pii: S1526-8209(22)00079.
    PubMed     Abstract available


  73. SNIDER K, Moore T, Walters C, Brachtenbach T, et al
    An Analysis of the Evidence Informing Clinical Practice Guidelines in the Management and Treatment of Breast Cancer.
    Clin Breast Cancer. 2022 Apr 29. pii: S1526-8209(22)00078.
    PubMed     Abstract available


  74. ARIFFIN NS
    RUNX1 as a Novel Molecular Target for Breast Cancer.
    Clin Breast Cancer. 2022 Apr 26. pii: S1526-8209(22)00075.
    PubMed     Abstract available


  75. MEHRAJ U, Alshehri B, Khan AA, Bhat AA, et al
    Expression Pattern and Prognostic Significance of Chemokines in Breast cancer: An Integrated Bioinformatics Analysis.
    Clin Breast Cancer. 2022 Apr 25. pii: S1526-8209(22)00077.
    PubMed     Abstract available


  76. YAMADA D, Ohde S, Kajiura Y, Yagishita K, et al
    Relationship Between Breast Density, Breast Cancer Subtypes, and Prognosis.
    Clin Breast Cancer. 2022 Apr 22. pii: S1526-8209(22)00074.
    PubMed     Abstract available


  77. VANGURI RS, Fenn KM, Kearney MR, Wang Q, et al
    Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer.
    Clin Breast Cancer. 2022 Apr 18. pii: S1526-8209(22)00071.
    PubMed     Abstract available


  78. UDDIN MN, Wang X
    Identification of Breast Cancer Subtypes Based on Gene Expression Profiles in Breast Cancer Stroma.
    Clin Breast Cancer. 2022 Apr 5. pii: S1526-8209(22)00070.
    PubMed     Abstract available


  79. TWELVES C, Bartsch R, Ben-Baruch NE, Borstnar S, et al
    The Place of Chemotherapy in The Evolving Treatment Landscape for Patients With HR-positive/HER2-negative MBC.
    Clin Breast Cancer. 2022;22:223-234.
    PubMed     Abstract available


  80. SHIN HJ, Choi WJ, Park SY, Ahn SH, et al
    Prediction of Underestimation Using Contrast-Enhanced Spectral Mammography in Patients Diagnosed as Ductal Carcinoma In Situ on Preoperative Core Biopsy.
    Clin Breast Cancer. 2022;22:e374-e386.
    PubMed     Abstract available


  81. ZENG A, Brennan ME, Young S, Mathieu E, et al
    The Effect of Supplemental Imaging on Interval Cancer Rates in Mammography Screening: Systematic Review.
    Clin Breast Cancer. 2022;22:212-222.
    PubMed     Abstract available


  82. BRADBURY M, Hutton B, Beltran-Bless AA, Alzahrani M, et al
    Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review.
    Clin Breast Cancer. 2022;22:e362-e373.
    PubMed     Abstract available


  83. LIN X, He Y, Fu S, Lin S, et al
    The Ultrasonographic Characteristics of Focal Fibrocystic Change of the Breast and Analysis of Misdiagnosis.
    Clin Breast Cancer. 2022;22:252-260.
    PubMed     Abstract available


  84. LOTZ M, Ghebremichael M, Chervinsky K, Zorc T, et al
    Effective Surveillance of High-Risk Women.
    Clin Breast Cancer. 2022;22:e263-e269.
    PubMed     Abstract available


    March 2022
  85. HE Y, Gao X, Wu J, Li X, et al
    Effect of Breast Conservation Therapy vs Mastectomy on Overall Survival and Breast Cancer-Specific Survival Among Men With Stage I-II Breast Cancer: Analysis of SEER, 2000-2018.
    Clin Breast Cancer. 2022 Mar 31. pii: S1526-8209(22)00069.
    PubMed     Abstract available


  86. JACOBS W, Schagen SB, Brouwer SM, Kieffer JM, et al
    The Effects of Being Informed About Chemotherapy-Related Cognitive Symptoms With And Without Self-Affirmation on Perceived Cognitive Symptoms of Breast Cancer Patients: A Randomized Prospective, Longitudinal Study.
    Clin Breast Cancer. 2022 Mar 26. pii: S1526-8209(22)00064.
    PubMed     Abstract available


  87. MARCZYK VR, Rosa DD, Maia AL, Goemann IM, et al
    Overall Survival for HER2-Positive Breast Cancer Patients in the HER2-Targeted Era: Evidence From a Population-Based Study.
    Clin Breast Cancer. 2022 Mar 23. pii: S1526-8209(22)00066.
    PubMed     Abstract available


  88. JIANG C, Zhang S, Qiao K, Xiu Y, et al
    The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2022 Mar 21. pii: S1526-8209(22)00065.
    PubMed     Abstract available


  89. FENG M, Yang Y, Liao W, Li Q, et al
    Margetuximab Versus Trastuzumab in Patients With Advanced Breast Cancer: A Cost-effectiveness Analysis.
    Clin Breast Cancer. 2022 Mar 17. pii: S1526-8209(22)00063.
    PubMed     Abstract available


  90. ZHENG Y, Jiang X, Wang M, Yang S, et al
    BMPR1B Polymorphisms (rs1434536 and rs1970801) are Associated With Breast Cancer Susceptibility in Northwest Chinese Han Females: A Case-Control Study.
    Clin Breast Cancer. 2022 Mar 14. pii: S1526-8209(22)00045.
    PubMed     Abstract available


    February 2022
  91. ROSSO C, Voutsadakis IA
    Characteristics, Clinical Differences and Outcomes of Breast Cancer Patients with Negative or Low HER2 Expression.
    Clin Breast Cancer. 2022 Feb 26. pii: S1526-8209(22)00042.
    PubMed     Abstract available


  92. LIN Y, Yang Y, Zhang X, Li W, et al
    Manual Lymphatic Drainage for Breast Cancer-related Lymphedema: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Clin Breast Cancer. 2022 Feb 24. pii: S1526-8209(22)00034.
    PubMed     Abstract available


  93. LI L, Xiong Y, Wang N, Zhu M, et al
    Breast Cancer Stem Cells-derived Extracellular Vesicles Affect PPARG Expression by Delivering MicroRNA-197 in Breast Cancer Cells.
    Clin Breast Cancer. 2022 Feb 11. pii: S1526-8209(22)00040.
    PubMed     Abstract available


  94. CANINO F, Omarini C, Cerma K, Moscetti L, et al
    Ocular Toxicity in Breast Cancer Management: Manual for The Oncologist.
    Clin Breast Cancer. 2022 Feb 7. pii: S1526-8209(22)00036.
    PubMed     Abstract available


  95. SONG Z, Li C, Zhou D, Liu J, et al
    Changes in Ki-67 in Residual Tumor and Outcome of Primary Inflammatory Breast Cancer Treated With Trimodality Therapy.
    Clin Breast Cancer. 2022 Feb 6. pii: S1526-8209(22)00035.
    PubMed     Abstract available


  96. LIBESMAN S, Zackrisson S, Hofvind S, Seidler AL, et al
    An individual participant data meta-analysis of breast cancer detection and recall rates for digital breast tomosynthesis versus digital mammography population screening.
    Clin Breast Cancer. 2022 Feb 6. pii: S1526-8209(22)00037.
    PubMed     Abstract available


  97. MACNAB MF, Slater G, Fuller M, Elsberger B, et al
    The Role of redo-Sentinel Lymph Node Biopsy in Patients With Prior Ipsilateral Breast Cancer Surgery.
    Clin Breast Cancer. 2022 Feb 3. pii: S1526-8209(22)00033.
    PubMed     Abstract available


  98. FISER CK, Kronenfeld JP, Liu SN, Goel N, et al
    Comparison of Immediate Breast Reconstruction Outcomes in Patients With and Without Prior Cosmetic Breast Surgery.
    Clin Breast Cancer. 2022;22:136-142.
    PubMed     Abstract available


  99. CHOE AI, Ismail R, Mack J, Walter V, et al
    Review of Variables Associated With Positive Surgical Margins Using Scout Reflector Localizations for Breast Conservation Therapy.
    Clin Breast Cancer. 2022;22:e232-e238.
    PubMed     Abstract available


  100. YI M, Peng C, Xia B, Gan L, et al
    CXCL8 Facilitates the Survival and Paclitaxel-Resistance of Triple-Negative Breast Cancers.
    Clin Breast Cancer. 2022;22:e191-e198.
    PubMed     Abstract available


  101. GUIRGUIS MS, Checka C, Adrada BE, Whitman GJ, et al
    Bracketing with Multiple Radioactive Seeds to Achieve Negative Margins in Breast Conservation Surgery: Multiple Seeds in Breast Surgery.
    Clin Breast Cancer. 2022;22:e158-e166.
    PubMed     Abstract available


    January 2022
  102. HAQUE W, Verma V, Schwartz MR, Lim B, et al
    Neoadjuvant Chemotherapy for Metaplastic Breast Cancer: Response Rates, Management, and Outcomes.
    Clin Breast Cancer. 2022 Jan 31. pii: S1526-8209(22)00021.
    PubMed     Abstract available


  103. EL-BASSIOUNY NA, Helmy MW, Hassan MAE, Khedr GA, et al
    The Cardioprotective Effect of Vitamin D in Breast Cancer Patients Receiving Adjuvant Doxorubicin Based Chemotherapy.
    Clin Breast Cancer. 2022 Jan 31. pii: S1526-8209(22)00024.
    PubMed     Abstract available


  104. BILANI N, Ladki S, Yaghi M, Main O, et al
    Factors Associated With the Decision to Decline Chemotherapy in Patients With Early-stage, ER+/HER2- Breast Cancer and High-risk Scoring on Genomic Assays.
    Clin Breast Cancer. 2022 Jan 22. pii: S1526-8209(22)00023.
    PubMed     Abstract available


  105. LIU J, Yu H, Cui H, Wei F, et al
    lncRNA LINC000466 Predicts the Prognosis and Promotes the Progression of Triple-negative Breast Cancer via Modulating miR-539-5p.
    Clin Breast Cancer. 2022 Jan 22. pii: S1526-8209(22)00026.
    PubMed     Abstract available


  106. GHANBARI M, Shahinfar H, Imani H, Safabakhsh M, et al
    Association of Empirically Derived Food-Based Inflammatory Potential of the Diet and Breast Cancer: A Hospital-Based Case-Control Study.
    Clin Breast Cancer. 2022 Jan 21. pii: S1526-8209(21)00371.
    PubMed     Abstract available


  107. ISHII T, Nakano E, Watanabe T, Higashi T, et al
    Cardiac Function Checkup During Trastuzumab Therapy Among Patients With Breast Cancer.
    Clin Breast Cancer. 2022 Jan 19. pii: S1526-8209(22)00020.
    PubMed     Abstract available


  108. WILLIAMS AD, Ciocca R, Sabol JL, Carp NZ, et al
    The use of neoadjuvant therapy increases the rate of breast conservation in men with locally advanced breast cancer.
    Clin Breast Cancer. 2022 Jan 16. pii: S1526-8209(22)00019.
    PubMed     Abstract available


  109. GALINDO CM, Oliveira Ganzella FA, Klassen G, Souza Ramos EA, et al
    Nuances of PFKFB3 Signaling in Breast Cancer.
    Clin Breast Cancer. 2022 Jan 15. pii: S1526-8209(22)00017.
    PubMed     Abstract available


  110. MERFELD EC, Burr AR, Brickson C, Neuman HB, et al
    De-escalating Locoregional Therapy for Axillary Micrometastases in Breast Cancer: How Much is Too Much?
    Clin Breast Cancer. 2022 Jan 12. pii: S1526-8209(22)00016.
    PubMed     Abstract available


  111. HADALIN V, Pislar N, Borstnar S, Matos E, et al
    Intraoperative Touch Imprint Cytology in Breast Cancer Patients After Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2022 Jan 5. pii: S1526-8209(21)00374.
    PubMed     Abstract available


  112. OBISPO B, Rogado J, Lara Alvarez MA
    The Other Cost of the Pandemic.
    Clin Breast Cancer. 2022;22:e108.
    PubMed    


  113. BERNINI M, Sordi S, Bembi N, Meattini I, et al
    Selective Denervation of Pectoralis Major Muscle Improves Cosmetic Outcome and Quality of Life in Retro-Pectoral Implant Based Breast Reconstruction.
    Clin Breast Cancer. 2022;22:60-66.
    PubMed     Abstract available


  114. KANG MM, Hasan Y, Waller J, Saulsberry L, et al
    Has Hypofractionated Whole-Breast Radiation Therapy Become the Standard of Care in the United States? An Updated Report from National Cancer Database.
    Clin Breast Cancer. 2022;22:e8-e20.
    PubMed     Abstract available


  115. WANG C, Tsang JY, Poon IK, Shao Y, et al
    An Evaluation of Clinicopathological Correlation and Outcome of Human Epidermal Growth Factor Receptor 2 Subgroups Reclassified According to the Latest ASCO/CAP Guideline.
    Clin Breast Cancer. 2022;22:e114-e122.
    PubMed     Abstract available


  116. VARGHESE J, Gohari S, Regrag F, Rizki H, et al
    Breast Density Notification: Current UK National Practice.
    Clin Breast Cancer. 2022;22:e101-e107.
    PubMed     Abstract available


  117. KOH J, Yoon Y, Kim S, Han K, et al
    Deep Learning for the Detection of Breast Cancers on Chest Computed Tomography.
    Clin Breast Cancer. 2022;22:26-31.
    PubMed     Abstract available


  118. AZHAR S, Wyatt LC, Jokhakar V, Patel S, et al
    Associations between Spiritual Health Locus of Control, Perceived Discrimination and Breast and Cervical Cancer Screening for Muslim American Women in New York City.
    Clin Breast Cancer. 2022 Jan 1. pii: S1526-8209(21)00373.
    PubMed     Abstract available


    December 2021
  119. WALSH EM, Mangini N, Fetting J, Armstrong D, et al
    Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes.
    Clin Breast Cancer. 2021 Dec 30. pii: S1526-8209(21)00358.
    PubMed     Abstract available


  120. RAMOS-MARTINEZ JC, Altamirano-Gomez G, Ramos-Martinez I, Valencia J, et al
    Prognostic Value of Galectin Expression in Patients with Breast Cancer: Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2021 Dec 29. pii: S1526-8209(21)00372.
    PubMed     Abstract available


  121. JERUSALEM G, Delea TE, Martin M, De Laurentiis M, et al
    Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR+/-HER2- Advanced Breast Cancer in the MONALEESA-3 Trial.
    Clin Breast Cancer. 2021 Dec 20. pii: S1526-8209(21)00369.
    PubMed     Abstract available


  122. KATHURIA-PRAKASH N, Antrim L, Hornstein N, Sun AW, et al
    Factors Associated With Hospitalization Among Breast Cancer Patients With COVID-19: A Diverse Multi-Center Los Angeles Cohort Study.
    Clin Breast Cancer. 2021 Dec 17. pii: S1526-8209(21)00356.
    PubMed     Abstract available


  123. DE GROEF A, Demeyer H, de Kinkelder C, Dukers-van Althuis S, et al
    Physical Activity Levels of Breast Cancer Patients Before Diagnosis Compared to a Reference Population: A Cross-Sectional Comparative Study.
    Clin Breast Cancer. 2021 Dec 16. pii: S1526-8209(21)00357.
    PubMed     Abstract available


  124. SHAFAEE MN, Makawita S, Lim B, Ellis MJ, et al
    Concurrent Chemo-radiation As a Means of Achieving Pathologic Complete Response in Triple Negative Breast Cancer.
    Clin Breast Cancer. 2021 Dec 14. pii: S1526-8209(21)00352.
    PubMed     Abstract available


  125. BIHAN-BENJAMIN CL, Bertrand C, Molinie F, Rogel A, et al
    Care pathway of women with interval breast cancer in 2016, based on medico-administrative data.
    Clin Breast Cancer. 2021 Dec 11. pii: S1526-8209(21)00353.
    PubMed     Abstract available


  126. WANG YS, Guo R, Yang DC, Xu Y, et al
    The Interaction of NTN4 and miR-17-92 Polymorphisms on Breast Cancer Susceptibility in a Chinese Population.
    Clin Breast Cancer. 2021 Dec 10. pii: S1526-8209(21)00354.
    PubMed     Abstract available


  127. ZOU H, Liu SH, Yang R, Wu XJ, et al
    Combination of Neutrophil-to-Lymphocyte Ratio and Red Cell Distribution Width With Serum Tumor Markers for the Differential Diagnosis of Breast Cancer and its Association With Pathological Features and Molecular Types.
    Clin Breast Cancer. 2021 Dec 3. pii: S1526-8209(21)00347.
    PubMed     Abstract available


  128. ANGARITA FA, Jedrzejko N, Eisen D, Muraca M, et al
    Primary Care Physicians' Perspectives in Leading Breast Cancer Follow-Up Care.
    Clin Breast Cancer. 2021 Dec 2. pii: S1526-8209(21)00350.
    PubMed     Abstract available


  129. CAPARICA R, Ma Y, De Angelis C, Richard F, et al
    Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial.
    Clin Breast Cancer. 2021 Dec 2. pii: S1526-8209(21)00351.
    PubMed     Abstract available


  130. MACHUCA MPG, Wu WC, Yu BL, Cheng CT, et al
    Determinants of Breast-Conserving Therapy in Early-Stage Breast Cancer Patients: A Nationwide Study.
    Clin Breast Cancer. 2021 Dec 2. pii: S1526-8209(21)00344.
    PubMed     Abstract available


  131. MAHTANI R, Oestreicher N, Lalla D, Ogbonnaya A, et al
    Health Care Resource Utilization and Costs for Metastatic Breast Cancer Patients Newly Treated with Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Agents.
    Clin Breast Cancer. 2021 Dec 2. pii: S1526-8209(21)00349.
    PubMed     Abstract available


  132. VIUFF JH, Greiber IK, Karlsen MA, Storgaard L, et al
    Survival in Women Diagnosed With Breast Cancer During Pregnancy.
    Clin Breast Cancer. 2021 Dec 1. pii: S1526-8209(21)00346.
    PubMed     Abstract available


  133. LIN J, Hu H, Shriver CD, Zhu K, et al
    Survival among Breast Cancer Patients: Comparison of the U.S. Military Health System with the Surveillance, Epidemiology and End Results Program.
    Clin Breast Cancer. 2021 Dec 1. pii: S1526-8209(21)00348.
    PubMed     Abstract available


  134. FODOR A, Brombin C, Mangili P, Tummineri R, et al
    Toxicity of Hypofractionated Whole Breast Radiotherapy Without Boost and Timescale of Late Skin Responses in a Large Cohort of Early-Stage Breast Cancer Patients.
    Clin Breast Cancer. 2021 Dec 1. pii: S1526-8209(21)00345.
    PubMed     Abstract available


  135. HARRIS EER
    Breast Radiation and the Heart: Cardiac Toxicity and Cardiac Avoidance.
    Clin Breast Cancer. 2021;21:492-496.
    PubMed     Abstract available


  136. GUO H, Idrovo JP, Cao J, Roychoudhury S, et al
    Human Papillomavirus (HPV) Detection by Chromogenic In Situ Hybridization (CISH) and p16 Immunohistochemistry (IHC) in Breast Intraductal Papilloma and Breast Carcinoma.
    Clin Breast Cancer. 2021;21:e638-e646.
    PubMed     Abstract available


  137. LISA A, Losurdo A, Testori A, Tinterri C, et al
    Comment on: "Oncologic Safety of Autologous Fat Grafting in Breast Reconstruction".
    Clin Breast Cancer. 2021;21:e693.
    PubMed    


  138. XU F, Li C, Li X, Huang Q, et al
    Competing-Risk Nomograms for Predicting the Prognosis of Patients With Infiltrating Lobular Carcinoma of the Breast.
    Clin Breast Cancer. 2021;21:e704-e714.
    PubMed     Abstract available


  139. VAN DE VOORT EMF, Struik GM, Birnie E, Moelker A, et al
    Thermal Ablation as an Alternative for Surgical Resection of Small (
    Clin Breast Cancer. 2021;21:e715-e730.
    PubMed     Abstract available


    November 2021
  140. CHIRADONI THUNGAPPA S, Maksud T, Raut N, Nagarkar R, et al
    Comparison of the Efficacy, Safety, Pharmacokinetic and Immunogenicity of UJVIRA (ZRC-3256, Trastuzumab Emtansine) With the Kadcyla (Trastuzumab Emtansine) in the Treatment of HER2-Positive Metastatic Breast Cancer: A Randomized, Open-Label, Multicent
    Clin Breast Cancer. 2021 Nov 27. pii: S1526-8209(21)00343.
    PubMed     Abstract available


  141. MULLANGI S, Vasan N
    Genomic Characterization of De Novo Metastatic Breast Cancer.
    Clin Breast Cancer. 2021 Nov 26. pii: S1526-8209(21)00342.
    PubMed     Abstract available


  142. AKINYEMIJU T, Oyekunle T, Salako O, Gupta A, et al
    Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: Analysis of the MEND Study.
    Clin Breast Cancer. 2021 Nov 23. pii: S1526-8209(21)00320.
    PubMed     Abstract available


  143. WOOSTER M, McGuinness JE, Fenn KM, Singh VM, et al
    Diagnosis of Leptomeningeal Metastasis in Women With Breast Cancer Through Identification of Tumor Cells in Cerebrospinal Fluid Using the CNSide Assay.
    Clin Breast Cancer. 2021 Nov 14. pii: S1526-8209(21)00318.
    PubMed     Abstract available


  144. LI GQ, Yao J, Zhou P, Chen DX, et al
    Distribution, Chemotherapy Use, and Outcome of the 21-Gene Recurrence Score Between Chinese and White breast Cancer in the United States.
    Clin Breast Cancer. 2021 Nov 14. pii: S1526-8209(21)00319.
    PubMed     Abstract available


  145. SHAHI S, Meza J, Tandra P, LeVan T, et al
    Gender Differences in Recommended Treatment Decisions among Breast Cancer Patients: A Study Using the National Cancer Database.
    Clin Breast Cancer. 2021 Nov 8. pii: S1526-8209(21)00307.
    PubMed     Abstract available


  146. SILVA DTC, Vanderlei LCM, Palma MR, Ribeiro FE, et al
    Association Between Different Domains of Physical Activity and Body Adiposity Indicators in Breast Cancer Survivors.
    Clin Breast Cancer. 2021 Nov 5. pii: S1526-8209(21)00306.
    PubMed     Abstract available


  147. KANESHIRO K, Kubo M, Taniguchi M, Yamada M, et al
    Current Status and Problems of Breast Cancer Treatment with Schizophrenia.
    Clin Breast Cancer. 2021 Nov 4. pii: S1526-8209(21)00297.
    PubMed     Abstract available


  148. XUE M, Che S, Tian Y, Xie L, et al
    Nomogram Based on Breast MRI and Clinicopathologic Features for Predicting Axillary Lymph Node Metastasis in Patients with Early-Stage Invasive Breast Cancer: A Retrospective Study.
    Clin Breast Cancer. 2021 Nov 1. pii: S1526-8209(21)00305.
    PubMed     Abstract available


    October 2021
  149. LI W, Hu S, Han Z, Jiang X, et al
    YY1-Induced Transcriptional Activation of FAM111B Contributes to the Malignancy of Breast Cancer.
    Clin Breast Cancer. 2021 Oct 29. pii: S1526-8209(21)00298.
    PubMed     Abstract available


  150. YARDLEY DA, Young RR, Adelson KB, Silber AL, et al
    A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC).
    Clin Breast Cancer. 2021 Oct 28. pii: S1526-8209(21)00302.
    PubMed     Abstract available


  151. BOLUKBASI Y, Oymak E, Sezen D, Onal C, et al
    Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Mono-Institutional Study: In Regard to De Matteis et al.
    Clin Breast Cancer. 2021 Oct 28. pii: S1526-8209(21)00303.
    PubMed    


  152. MEANS-POWELL JA, Mayer IA, Ismail-Khan R, Del Valle L, et al
    A Phase Ib Dose Escalation Trial of RO4929097 (a gamma-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC).
    Clin Breast Cancer. 2021 Oct 28. pii: S1526-8209(21)00304.
    PubMed     Abstract available


  153. MILTON L, Behroozian T, Li N, Zhang L, et al
    Symptom Burden Associated With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy.
    Clin Breast Cancer. 2021 Oct 13. pii: S1526-8209(21)00296.
    PubMed     Abstract available


  154. MO H, Renna CE, Moore HCF, Abraham J, et al
    Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors.
    Clin Breast Cancer. 2021 Oct 9. pii: S1526-8209(21)00293.
    PubMed     Abstract available


  155. CONTE B, Soldato D, Razeti MG, Fregatti P, et al
    De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence.
    Clin Breast Cancer. 2021 Oct 8. pii: S1526-8209(21)00292.
    PubMed     Abstract available


  156. BENOIT L, Cambra C, Rouzier R, Cottu P, et al
    Quality of Life in an e-Cohort of Women Treated by Endocrine Therapy for Early Breast Cancer.
    Clin Breast Cancer. 2021 Oct 1. pii: S1526-8209(21)00291.
    PubMed     Abstract available


  157. DUDLEY CM, Wiener AA, Stankowski-Drengler TJ, Schumacher JR, et al
    Rates of Ipsilateral Local-regional Recurrence in High-risk Patients Undergoing Immediate Post-mastectomy Reconstruction (AFT-01).
    Clin Breast Cancer. 2021;21:433-439.
    PubMed     Abstract available


  158. HSIEH K, Housri N, Haffty B, Smith B, et al
    Radiation Oncologists' Views on Breast Radiation Therapy Guidelines: Utilizing an Online Q&A Platform to Assess Current Views on Whole-Breast Irradiation Therapy.
    Clin Breast Cancer. 2021;21:408-416.
    PubMed     Abstract available


  159. DAVIS J JR, Boughey JC, Hoskin TL, Day CN, et al
    Locoregional Management of the Axilla in Mastectomy Patients with One or Two Positive Sentinel Nodes: The Role of Intraoperative Pathology.
    Clin Breast Cancer. 2021;21:458-465.
    PubMed     Abstract available


  160. VARTHOLOMATOS G, Harissis H, Andreou M, Tatsi V, et al
    Rapid Assessment of Resection Margins During Breast Conserving Surgery Using Intraoperative Flow Cytometry.
    Clin Breast Cancer. 2021;21:e602-e610.
    PubMed     Abstract available


  161. CARTAGENA LC, McGuire K, Zot P, Pillappa R, et al
    Breast-Conserving Surgeries With and Without Cavity Shave Margins Have Different Re-excision Rates and Associated Overall Cost: Institutional and Patient-Driven Decisions for Its Utilization.
    Clin Breast Cancer. 2021;21:e594-e601.
    PubMed     Abstract available


  162. WU JM, Turashvili G
    A Survey of Breast Pathologists' Practice in Staging Multiple Foci of Invasive Carcinoma.
    Clin Breast Cancer. 2021;21:e506-e511.
    PubMed     Abstract available


    September 2021
  163. GULER OC, Onal C
    Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients with Pathologic Negative Nodes after Neoadjuvant Chemotherapy. In regard to Schlafstein et al.
    Clin Breast Cancer. 2021 Sep 29. pii: S1526-8209(21)00288.
    PubMed    


  164. JIA H, Zheng Y, Wang P, Wei Z, et al
    A Retrospective Study on the Clinicopathologic Characteristics and Outcomes of 179 Cases of Synchronous and Metachronous Bilateral Breast Cancer in China.
    Clin Breast Cancer. 2021 Sep 29. pii: S1526-8209(21)00289.
    PubMed     Abstract available


  165. DE MATTEIS S, Facondo G, Valeriani M, Vullo G, et al
    Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Monoistitutional Study.
    Clin Breast Cancer. 2021 Sep 25. pii: S1526-8209(21)00266.
    PubMed     Abstract available


  166. SEALE KN, Tkaczuk KHR
    Circulating Biomarkers in Breast Cancer.
    Clin Breast Cancer. 2021 Sep 22. pii: S1526-8209(21)00264.
    PubMed     Abstract available


  167. JUNG L, Miske A, Indorf A, Nelson K, et al
    A Retrospective Analysis of Metronomic Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) Versus Docetaxel and Cyclophosphamide (TC) as Adjuvant Treatment in Early Stage, Hormone Receptor Positive, HER2 Negative Breast Cancer.
    Clin Breast Cancer. 2021 Sep 22. pii: S1526-8209(21)00265.
    PubMed     Abstract available


  168. BARLUND M, Takala L, Tianen L, Kellokumpu-Lehtinen PL, et al
    Real-world Evidence of Implementing eHealth Enables Fluent Symptom-based Follow-up of a Growing Number of Patients with Breast Cancer with the Same Healthcare Resources.
    Clin Breast Cancer. 2021 Sep 20. pii: S1526-8209(21)00263.
    PubMed     Abstract available


  169. SAKACH E, O'Regan R, Meisel J, Li X, et al
    Molecular Classification of Triple Negative Breast Cancer and the Emergence of Targeted Therapies.
    Clin Breast Cancer. 2021 Sep 17. pii: S1526-8209(21)00261.
    PubMed     Abstract available


  170. LEVASSEUR N, Sun J, Fenton D, Baxter S, et al
    Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility Study.
    Clin Breast Cancer. 2021 Sep 17. pii: S1526-8209(21)00262.
    PubMed     Abstract available


  171. LI Y, Lin Q, Lu X, Li W, et al
    Post-Diagnosis use of Antioxidant Vitamin Supplements and Breast Cancer Prognosis: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2021 Sep 12. pii: S1526-8209(21)00259.
    PubMed     Abstract available


  172. RAO MALLA R, Marni R, Kumari S, Chakraborty A, et al
    Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer.
    Clin Breast Cancer. 2021 Sep 12. pii: S1526-8209(21)00260.
    PubMed     Abstract available


    August 2021
  173. LI J, Li Y, Cheng H
    Circ-RPPH1 knockdown retards breast cancer progression via miR-328-3p-mediated suppression of HMGA2.
    Clin Breast Cancer. 2021 Aug 31. pii: S1526-8209(21)00247.
    PubMed     Abstract available


  174. RIBATTI D, Annese T, Tamma R
    Controversial role of mast cells in breast cancer tumor progression and angiogenesis.
    Clin Breast Cancer. 2021 Aug 31. pii: S1526-8209(21)00246.
    PubMed     Abstract available


  175. ZHU J, Zheng H, Ge C, Lin H, et al
    Competing Nomogram for Late-Period Breast Cancer-Specific Death in Patients with Early-Stage Hormone Receptor-Positive Breast Cancer.
    Clin Breast Cancer. 2021 Aug 31. pii: S1526-8209(21)00245.
    PubMed     Abstract available


  176. SINCLAIR WD, Cui X
    The Effects of HER2 on CDK4/6 Activity in Breast Cancer.
    Clin Breast Cancer. 2021 Aug 26. pii: S1526-8209(21)00244.
    PubMed     Abstract available


  177. LORUSSO P, Hamilton E, Ma C, Vidula N, et al
    A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer.
    Clin Breast Cancer. 2021 Aug 20. pii: S1526-8209(21)00240.
    PubMed     Abstract available


  178. LI Q, Wang K, Yang L, Wu Q, et al
    Long-term Survival Comparison of Repeated Breast-conserving Surgery Versus Mastectomy for Patients with DCIS with Ipsilateral Breast Tumor Recurrence: A Real-world Longitudinal Study.
    Clin Breast Cancer. 2021;21:360-372.
    PubMed     Abstract available


  179. HADADI I, Rae W, Clarke J, McEntee M, et al
    Diagnostic Performance of Adjunctive Imaging Modalities Compared to Mammography Alone in Women with Non-Dense and Dense Breasts: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2021;21:278-291.
    PubMed     Abstract available


  180. SHAMOUN F, Asaad M, Hanson SE
    Oncologic Safety of Autologous Fat Grafting in Breast Reconstruction.
    Clin Breast Cancer. 2021;21:271-277.
    PubMed     Abstract available


  181. SALGARELLO M, Pagliara D, Barone Adesi L, Visconti G, et al
    Direct to Implant Breast Reconstruction With Prepectoral Micropolyurethane Foam-Coated Implant: Analysis of Patient Satisfaction.
    Clin Breast Cancer. 2021;21:e454-e461.
    PubMed     Abstract available


  182. AFSHARFARD A, Ebrahimibagha H, Zeinalpour A
    A Novel Local Transposition Flap for Lateral Breast Reconstruction After Breast Conserving Surgery.
    Clin Breast Cancer. 2021;21:e448-e453.
    PubMed     Abstract available


  183. YAMASHITA Y, Tsunoda H, Nagura N, Kajiura Y, et al
    Long-Term Oncologic Safety of Nipple-Sparing Mastectomy With Immediate Reconstruction.
    Clin Breast Cancer. 2021;21:352-359.
    PubMed     Abstract available


  184. MENG X, Ma H, Yin H, Yin H, et al
    Nomogram Predicting the Risk of Locoregional Recurrence After Mastectomy for Invasive Micropapillary Carcinoma of the Breast.
    Clin Breast Cancer. 2021;21:e368-e376.
    PubMed     Abstract available


  185. GOYAL U, Saboda K, Roe D, Gonzalez VJ, et al
    Prone Positioning With Deep Inspiration Breath Hold for Left Breast Radiotherapy.
    Clin Breast Cancer. 2021;21:e295-e301.
    PubMed     Abstract available


  186. CAPUTO GG, Zingaretti N, Kiprianidis I, Zanfisi C, et al
    Quality of Life and Early Functional Evaluation in Direct-to-Implant Breast Reconstruction After Mastectomy: A Comparative Study Between Prepectoral Versus Dual-Plane Reconstruction.
    Clin Breast Cancer. 2021;21:344-351.
    PubMed     Abstract available


    July 2021
  187. TOORANG F, Sasanfar B, Esmaillzadeh A, Zendehdel K, et al
    Adherence to the DASH Diet and Risk of Breast Cancer.
    Clin Breast Cancer. 2021 Jul 31. pii: S1526-8209(21)00198.
    PubMed     Abstract available


    June 2021
  188. FORTUNATO L, Loreti A, Cortese G, Spallone D, et al
    Regret and Quality of Life After Mastectomy With or Without Reconstruction.
    Clin Breast Cancer. 2021;21:162-169.
    PubMed     Abstract available


  189. ABOUELAZAYEM M, Elkorety M, Monib S
    Breast Lymphedema After Conservative Breast Surgery: An Up-to-date Systematic Review.
    Clin Breast Cancer. 2021;21:156-161.
    PubMed     Abstract available


  190. BRUNO E, Oliverio A, Paradiso A, Daniele A, et al
    Lifestyle Characteristics in Women Carriers of BRCA Mutations: Results From an Italian Trial Cohort.
    Clin Breast Cancer. 2021;21:e168-e176.
    PubMed     Abstract available


  191. JAFFERBHOY SF, Goussous G, Chandarana M, Salehi-Bird S, et al
    Impact of Preoperative MRI in Invasive Ductal Carcinoma With Lobular Features on Core Biopsy.
    Clin Breast Cancer. 2021;21:e194-e198.
    PubMed     Abstract available


  192. LONG R, Cao K, Cao M, Li XT, et al
    Improving the Diagnostic Accuracy of Breast BI-RADS 4 Microcalcification-Only Lesions Using Contrast-Enhanced Mammography.
    Clin Breast Cancer. 2021;21:256-262.
    PubMed     Abstract available


  193. KIM H, Vargo JA, Smith KJ, Beriwal S, et al
    Cost-Effectiveness Analysis of Biological Signature DCISionRT Use for DCIS Treatment.
    Clin Breast Cancer. 2021;21:e271-e278.
    PubMed     Abstract available


  194. DE OLIVEIRA-JUNIOR I, Brandini da Silva FC, Nazima F, Ribeiro JC Jr, et al
    Oncoplastic Surgery: Does Patient and Medical Specialty Influences the Evaluation of Cosmetic Results?
    Clin Breast Cancer. 2021;21:247-255.
    PubMed     Abstract available


  195. NAIR NS, Chitkara G, Hawaldar RW, Parmar V, et al
    En Bloc Excision of Phyllodes Tumor of the Breast: Radical Approach Heralds Better Outcome.
    Clin Breast Cancer. 2021;21:e228-e234.
    PubMed     Abstract available


  196. COBB AN, Janjua HM, Kuo PC
    Big Data Solutions for Controversies in Breast Cancer Treatment.
    Clin Breast Cancer. 2021;21:e199-e203.
    PubMed     Abstract available


  197. ANDRIKOPOULOU A, Zografos E, Liontos M, Koutsoukos K, et al
    Trastuzumab Deruxtecan (DS-8201a): The Latest Research and Advances in Breast Cancer.
    Clin Breast Cancer. 2021;21:e212-e219.
    PubMed     Abstract available


  198. BILANI N, Elson L, Liang H, Elimimian EB, et al
    Effect of Surgery at Primary and Metastatic Sites in Patients With Stage IV Breast Cancer.
    Clin Breast Cancer. 2021;21:170-180.
    PubMed     Abstract available


  199. SUN J, Henry DA, Carr MJ, Yazdankhahkenary A, et al
    Feasibility of Axillary Lymph Node Localization and Excision Using Radar Reflector Localization.
    Clin Breast Cancer. 2021;21:e189-e193.
    PubMed     Abstract available


    April 2021
  200. WISINSKI K, O'Regan R
    Introduction to Special Issue.
    Clin Breast Cancer. 2021;21:95.
    PubMed    


  201. MONTAGNA G, Morrow M
    Breast-conserving Surgery Without Radiation Therapy for Invasive Cancer.
    Clin Breast Cancer. 2021;21:112-119.
    PubMed     Abstract available


  202. HEPEL JT, Wazer DE
    Update on Partial Breast Irradiation.
    Clin Breast Cancer. 2021;21:96-102.
    PubMed     Abstract available


    February 2021
  203. ERNST A, Flynn KE, Weil EM, Crotty BH, et al
    Aromatase Inhibitor Symptom Management Practices: A Retrospective Study.
    Clin Breast Cancer. 2021;21:e38-e47.
    PubMed     Abstract available


  204. INUZUKA M, Watanabe C, Yokoyama S, Kuwayama T, et al
    A Retrospective Analysis of the Relationship Between the Result of BRCA1/2 Genetic Testing and Surgical Method Selection in Japan.
    Clin Breast Cancer. 2021;21:e48-e52.
    PubMed     Abstract available


  205. SAVVA C, Sadiq M, Sheikh O, Karim S, et al
    Werner Syndrome Protein Expression in Breast Cancer.
    Clin Breast Cancer. 2021;21:57-73.
    PubMed     Abstract available


  206. JOHN P, Osani MC, Kodali A, Buchsbaum R, et al
    Comparative Effectiveness of Adjuvant Chemotherapy in Early-Stage Breast Cancer: A Network Meta-analysis.
    Clin Breast Cancer. 2021;21:e22-e37.
    PubMed     Abstract available


  207. MATHIAS BJ, Sun J, Sun W, Zhou JM, et al
    Surgeon Bias in the Management of Positive Sentinel Lymph Nodes.
    Clin Breast Cancer. 2021;21:74-79.
    PubMed     Abstract available


  208. PATEL BK, Samreen N, Zhou Y, Chen J, et al
    MR Elastography of the Breast: Evolution of Technique, Case Examples, and Future Directions.
    Clin Breast Cancer. 2021;21:e102-e111.
    PubMed     Abstract available


  209. GOFF SL, Danforth DN
    The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer.
    Clin Breast Cancer. 2021;21:e63-e73.
    PubMed     Abstract available


  210. EARLY AP, Moon W
    Breast Cancer and Secondary Cancer Recurrences After Autologous Tissue Reconstruction.
    Clin Breast Cancer. 2021;21:e96-e101.
    PubMed     Abstract available


  211. GADDAM S, Heller SL, Babb JS, Gao Y, et al
    Male Breast Cancer Risk Assessment and Screening Recommendations in High-Risk Men Who Undergo Genetic Counseling and Multigene Panel Testing.
    Clin Breast Cancer. 2021;21:e74-e79.
    PubMed     Abstract available


  212. RUIZ-CASADO A, Alvarez-Bustos A, de Pedro CG, Mendez-Otero M, et al
    Cancer-related Fatigue in Breast Cancer Survivors: A Review.
    Clin Breast Cancer. 2021;21:10-25.
    PubMed     Abstract available


  213. MCDONOUGH AL, Lei Y, Kwak AH, Haggett DE, et al
    Implementation of a Brief Screening Tool to Identify Needs of Breast Cancer Survivors.
    Clin Breast Cancer. 2021;21:e88-e95.
    PubMed     Abstract available


  214. TUFANO AM, Teplinsky E, Landry CA
    Updates in Neoadjuvant Therapy for Triple Negative Breast Cancer.
    Clin Breast Cancer. 2021;21:1-9.
    PubMed     Abstract available


  215. KIM DW, Kim JS, Kim K, Shin KH, et al
    Spontaneous Rib Fractures After Breast Cancer Treatment Based on Bone Scans: Comparison Of Conventional Versus Hypofractionated Radiotherapy.
    Clin Breast Cancer. 2021;21:e80-e87.
    PubMed     Abstract available


  216. SAYAN M, Vergalasova I, Jhawar S, Kumar S, et al
    Utilization of Hypofractionated Whole-Breast Radiotherapy With Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy.
    Clin Breast Cancer. 2021;21:31-36.
    PubMed     Abstract available


  217. PARIS I, Di Giorgio D, Carbognin L, Corrado G, et al
    Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach.
    Clin Breast Cancer. 2021;21:e120-e127.
    PubMed     Abstract available


  218. WAN C, Williams CP, Nipp RD, Pisu M, et al
    Treatment Decision Making and Financial Toxicity in Women With Metastatic Breast Cancer.
    Clin Breast Cancer. 2021;21:37-46.
    PubMed     Abstract available


  219. TSAI ML, Knaack M, Martone P, Krueger J, et al
    Effects of Germline Pathogenic Variants, Cancer Subtypes, Tumor-related Characteristics, and Pregnancy-associated Diagnosis on Outcomes.
    Clin Breast Cancer. 2021;21:47-56.
    PubMed     Abstract available


  220. VILLASCO A, Agnelli F, D'Alonzo M, Accomasso F, et al
    Validation of CTS5 on a Retrospective Cohort of Real-Life Pre- and Postmenopausal Patients Diagnosed With Estrogen Receptor-Positive Breast Cancers: Is It Prognostic?
    Clin Breast Cancer. 2021;21:e53-e62.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: